 "Themis Medicare hits record high on strong Q2 results")
Themis Medicare has locked in upper circuit for seven straight trading days, up 5% at Rs 376, also its record high on the BSE, after the company reported a consolidated net profit at Rs 6.59 crore for the quarter ended September 2015 (Q2).
The pharmaceutical company had net loss of Rs 58 lakh in the same quarter year ago.
Net sales of the company during the quarter increased by 49% at Rs 63.13 crore against Rs 42.80 crore in the corresponding quarter of previous fiscal.
The company said change in sales mix coupled with reduction in finance cost has resulted in improved bottom line working for the half year on consolidated basis with profit before tax of Rs 12.42 crore against Rs 3.19 crore.
Post Q2 results, the stock zoomed 40% from Rs 268 on November 4, 2015 compared to 3% decline in S&P BSE Sensex.
Till 02:00 PM, a combined 43,111 shares changed hands and there were pending buy orders for 26,347 shares on the BSE and NSE.
The pharmaceutical company had net loss of Rs 58 lakh in the same quarter year ago.
Net sales of the company during the quarter increased by 49% at Rs 63.13 crore against Rs 42.80 crore in the corresponding quarter of previous fiscal.
The company said change in sales mix coupled with reduction in finance cost has resulted in improved bottom line working for the half year on consolidated basis with profit before tax of Rs 12.42 crore against Rs 3.19 crore.
Post Q2 results, the stock zoomed 40% from Rs 268 on November 4, 2015 compared to 3% decline in S&P BSE Sensex.
Till 02:00 PM, a combined 43,111 shares changed hands and there were pending buy orders for 26,347 shares on the BSE and NSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%